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Abstract. 
 
Previously we reported that annexin VI is re-
quired for the budding of clathrin-coated pits from hu-
man fibroblast plasma membranes in vitro. Here we 
 
show that annexin VI bound to the NH
 
2
 
-terminal 28-kD 
portion of membrane spectrin is as effective as cytosolic 
annexin VI in supporting coated pit budding. Annexin 
VI–dependent budding is accompanied by the loss of 
 
z
 
50% of the spectrin from the membrane and is 
 
blocked by the cysteine protease inhibitor 
 
N
 
-acetyl-
leucyl-leucyl-norleucinal (ALLN). Incubation of fibro-
blasts in the presence of ALLN initially blocks the up-
take of low density lipoprotein (LDL), but the cells 
recover after 1 h and internalize LDL with normal 
kinetics. The LDL internalized under these conditions, 
however, fails to migrate to the center of the cell and is 
not degraded. ALLN-treated cells have twice as many 
coated pits and twofold more membrane clathrin, sug-
gesting that new coated pits have assembled. Annexin 
VI is not required for the budding of these new coated 
pits and ALLN does not inhibit. Finally, microinjection 
of a truncated annexin VI that inhibits budding in vitro 
has the same effect on LDL internalization as ALLN. 
These findings suggest that fibroblasts are able to make 
at least two types of coated pits, one of which requires 
the annexin VI–dependent activation of a cysteine pro-
tease to disconnect the clathrin lattice from the spectrin 
membrane cytoskeleton during the final stages of bud-
ding.
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docytosis
 
R
 
eceptor-mediated
 
 endocytosis of macromolecules
depends on the coordinate regulation of receptor
sequestration and plasma membrane budding by
clathrin-coated pits (3, 51). Coated vesicle formation be-
gins with the assembly of the clathrin lattice and ends with
the release of the nascent vesicle after membrane scission.
Budding reactions like this are common during intracellu-
lar membrane traffic (48, 50) and most appear to be medi-
ated by a coat protein complex. These coats are thought to
actively shape the membrane into a vesicle. They may also
remodel the lipid and cytoskeletal components of the
membrane in preparation for the scission reaction.
Two in vitro systems that reconstitute clathrin-coated
pit budding have provided new insights into how coated
vesicles form. One system uses perforated A431 cells,
which lack cytoplasm but retain many of the regulatory el-
ements required to control receptor clustering and coated
pit budding (51). The other system uses purified human fi-
broblast plasma membranes containing LDL receptors
clustered in coated pits. When these membranes are at-
tached to a solid substratum at 4
 
8
 
C, invagination of pits oc-
curs spontaneously upon warming to 37
 
8
 
C. The scission
step, however, requires ATP, Ca
 
1
 
2
 
, and cytosol (39). One
of the cytosolic proteins essential for scission in this in
vitro system is annexin VI (40).
Annexin VI belongs to a family of Ca
 
1
 
2
 
-dependent,
phospholipid-binding proteins (16). Each annexin has a
variable NH
 
2
 
-terminal region and a conserved COOH-ter-
minal domain called the core (47). The core usually con-
tains four 70-amino-acid long calcium-binding repeats.
Annexin VI, however, has eight of these repeats. Several
studies indicate annexins play a role in membrane traffic.
Annexin VII (synexin) mediates membrane fusion be-
tween chromaffin secretory vesicles in vitro (16). Annexin
II appears to be involved in membrane fusion between iso-
lated endosomal vesicles (42), is transferred between en-
dosomes during fusion in vitro (19), and rapidly redistrib-
utes from the basolateral surface to the apical surface
during the transcytosis of glycolithocholate in hepatocytes
(60). Annexin II also translocates to the plasma membrane
during exocytosis (13). Annexin I is localized to multive-
sicular bodies and it may be involved in inward vesicula-
tion of these membranes (21). Finally, annexin XIIIb has
been implicated in vesicle targeting to the apical surface of
MDCK cells (20).
Several annexins have been found to bind actin and
spectrin in vitro, raising the possibility they participate in
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remodeling of the spectrin cytoskeleton (47). Annexin VI,
for example, binds to the NH
 
2
 
-terminal 28-kD portion of
 
b
 
-spectrin and this interaction inhibits the ability of spec-
trin to cross-link actin (59). Spectrin, which is an extended,
rod-shaped tetramer composed of two 
 
a
 
 and two 
 
b
 
 sub-
units, forms a cytoskeletal meshwork with actin and other
accessory proteins that lines the inner surface of most
metazoan cells (10, 24). Several studies suggest that re-
modeling of this meshwork precedes exocytosis. Stimula-
tion of exocytosis in chromaffin cells causes the depo-
lymerization of membrane-associated F-actin and the
reorganization of spectrin into discrete patches on the
plasma membrane (7, 56). Antibodies to 
 
a
 
-spectrin inhibit
exocytosis in these cells, suggesting spectrin must be dis-
placed from sites where vesicles dock and fuse (46). The
removal of spectrin may be mediated by the cysteine pro-
tease calpain I. Calpain I cleaves both the 
 
a
 
 and 
 
b
 
 subunits
of brain spectrin, producing subunits that are no longer
able to form tetramers or interact with actin (31). Limited
proteolysis by calpain also inhibits spectrin from associat-
ing with membrane-binding sites (34).
The remodeling of the spectrin–actin cytoskeleton may
also be required for endocytosis. For example, endocytosis
in erythrocyte ghosts, which is not clathrin mediated, is
preceded by the formation of spectrin-free zones at sites of
membrane budding (29, 30). It is not known if there is a
similar requirement during coated pit budding. However,
the recent localization of calpain I to isolated coated vesi-
cles (49) together with the finding that annexin VI binds
spectrin (59) and is required for clathrin-coated vesicle
budding in vitro (40), suggests a reorganization of the
spectrin cytoskeleton might be part of the clathrin budding
reaction. Here we report that the binding of annexin VI to
spectrin causes the cysteine protease-dependent loss of
membrane spectrin. Reagents that block spectrin loss pre-
vent budding both in vivo and in vitro. Cells adapt to the
presence of this class of inhibitors by forming a new set of
coated pits that are able to bud independently of annexin
VI and spectrin removal. The endosomes that form from
these pits, however, are unable to carry low density lipo-
protein (LDL)
 
1 
 
to the center of the cell and LDL is not de-
graded.
 
Materials and Methods
 
Materials
 
Coverslips (12-mm round) were obtained from Fisher Scientific Co. (Pitts-
burgh, PA). 
 
125
 
I-labeled streptavidin (IM 236) was purchased from Amer-
sham Pharmacia Biotech., Inc. (Piscataway, NJ). The following tissue cul-
ture agents were obtained from Gibco Laboratories (Grand Island, NY):
Dulbecco’s modified Eagle’s medium (DME, 320–885), Eagle’s minimal
essential medium (EMEM; 330–1,435), fetal calf serum (FCS; 200–6,140),
and penicillin-streptomycin (600–5,145). Human lipoprotein-deficient se-
rum (H-LPPS) was prepared by ultracentrifugation of human plasma (22).
SlowFade™ light antifade kit was obtained from Molecular Probes, Inc.
(Eugene, OR). Isopropyl-
 
b
 
-
 
d
 
-thiogalactopyranoside was obtained from
Stratagene (La Jolla, CA). The following reagents were obtained from
Sigma Chemical Co. (St. Louis, MO): poly-
 
l
 
-lysine (P-1524), Hepes (H-
3372), PMSF (P-7626), BSA fraction V (A-7906), crystalline BSA (c-BSA;
A-7638), ATP (A-5394), thrombin (T-7513), and glutathione-agarose (G-
4510). Leupeptin (62070), dithiothreitol (DTT; 43819) and paraformalde-
 
hyde (76240) were obtained from Fluka Chemika-Biochemika (Ronkonkoma,
NY). Human recombinant calpastatin (208900) and calpain I inhibitor
(208719, 
 
N
 
-acetyl-leucyl-leucyl-norleucinal [ALLN]) was purchased from
Calbiochem-Novabiochem (La Jolla, CA). Biotinylated horse anti–mouse
IgG (BA-2000) was purchased from Vector Labs, Inc. (Burlingame, CA).
The mouse mAbs used in these experiments were: anticlathrin heavy
chain (X-22), provided by F. Brodsky [University of California, San Fran-
cisco, CA]; anti–annexin VI IgG from Zymed Labs, Inc. (03-4900; South
San Francisco, CA) and antispectrin IgG from Sigma Chemical Co.
(S-3396). Rabbit pAb to spectrin was from Sigma Chemical Co. (S-1515).
The 
 
125
 
I-labeled LDL was prepared as previously described (22).
 
 
 
Fluores-
cent LDL (pMCA-oleate LDL) was prepared as previously described (2).
 
Methods
 
Media and Buffers.  
 
Medium A: DME containing 10% FCS, 20 mM
Hepes, pH 7.4, 100 U/ml penicillin, and 100 
 
m
 
g/ml streptomycin. Medium
B: DME containing 10% FCS, 100 U/ml penicillin, and 100 
 
m
 
g/ml strepto-
mycin. Medium C: EMEM containing 20 mM Hepes, pH 7.4. Buffer A: 50
mM Hepes-NaOH, pH 7.4, 100 mM NaCl. Buffer B: 25 mM Hepes-KOH,
pH 7.0, 25 mM KCl, 2.5 mM magnesium acetate, 0.2 mM DTT. Buffer C:
2.3 mM NaH
 
2
 
PO
 
4
 
·H
 
2
 
O, 7.7 mM Na
 
2
 
HPO
 
4
 
·7 H
 
2
 
O, 150 mM NaCl, 2 mM
MgCl
 
2
 
, pH 7.4.
 
Cell Culture. 
 
All the in vitro
 
 
 
experiments used SV-40–transformed hu-
man fibroblasts (designated SV589) as previously described. All in vivo
experiments used normal human fibroblasts. SV589 cells were grown as
monolayers in medium A and set up for experiments according to a stan-
dard format (39). Normal human fibroblasts were grown in medium B and
induced to express LDL receptors by replacing the fetal calf serum with
human lipoprotein deficient serum as previously described (22).
 
Recombinant Proteins. 
 
Plasmids encoding COOH-terminal deletions
of annexin VI fused with glutathione-S-transferase (GST) were con-
structed by selective PCR amplification of the corresponding cDNA se-
quences using oligonucleotides containing flanking restriction sites. The
resulting PCR fragments were first cloned into the pCR II vector (Strat-
agene, La Jolla, CA) and then into the GST expression vector pGEX-KG
(28). Oligonucleotide primers used for PCR were: AnxVI
 
wt
 
 (residues 1–673),
oligonucleotides A (TCTAGACATGGCCAAACCAGCACAGGG) and
B (CGCGTCGACCTAGTCCTCACCACCACAGAGAGC); AnxVI
 
D
 
379
 
(residues 1–379), oligonucleotide A and C (CGCGTCGACCTAGA-
GTCCCTTCATGGCTTTCCG); and AnxVI
 
D
 
192
 
 (residues 1–192), oligo-
nucleotide A and D (CGCGTCGACCTACCAT TTCAGTTCCCCTGC-
CTC). PCR fragments were digested with XbaI and SalI and cloned into
pGEX-KG. Recombinant proteins were purified by affinity chromatogra-
phy on glutathione-agarose beads as previously described (58), with the
modification that the purified fusion protein was released from glu-
tathione beads by digesting with thrombin (16 U/ml of beads) for 1 h at
room temperature. The released protein was dialyzed in buffer B over-
night at 4
 
8
 
C and stored at 
 
2
 
80
 
8
 
C.
Plasmid encoding residues 1–272 of 
 
b
 
-spectrin fused with GST was con-
structed by PCR amplification from an NH
 
2
 
-terminal fragment of human
 
b
 
-spectrin (
 
b
 
 5.1) generously provided by V. Bennett (Duke University,
Durham, NC) (34). The oligonucleotides used to clone 
 
b
 
-spec
 
1–272
 
 were:
CGGGATCCCGTGAGCTGA AGCAGGGCA and CCCAAGCTTC-
TATTGTCTTCAGTTTCC. PCR fragments were digested with BamHI
and HindIII and then cloned into pGEX-KG. The proteins were then pu-
rified by affinity chromatography as described above.
 
In Vitro Budding Assay. 
 
Membranes were prepared as previously de-
scribed (39). In brief, SV589 cells were attached to poly-
 
l
 
-lysine–coated
coverslips by centrifugation (1,800 
 
g
 
) at 4
 
8
 
C, incubated with ice-cold me-
dium C containing 2% BSA for 1 h, washed quickly with buffer A and
buffer B at 4
 
8
 
C, and then sonicated in buffer B on ice. The attached mem-
branes were washed three times with ice-cold buffer B and either fixed im-
mediately or treated as indicated. Previously we used annexin VI–depleted
bovine cytosol containing 1 mM ATP and 150 
 
m
 
M calcium as the starting
material for all budding reactions (40). We noted while doing those stud-
ies, however, that often during the preparation of cytosol the annexin VI
budding activity was lost. We took advantage of this property in the cur-
rent study and always used as our starting material bovine brain cytosol
lacking annexin VI budding activity. To initiate budding, membranes were
incubated for 10 min at 37
 
8
 
C in the presence of the inactive bovine brain
cytosol (we refer to this as cytosol throughout the paper) that had been di-
alyzed against buffer B (final concentration in buffer B, 10 mg/ml) plus 1
mM ATP, 150 
 
m
 
M Ca
 
1
 
2 
 
and the indicated additions. The membranes were
then washed three times with ice-cold buffer B and fixed with 3%
 
1. 
 
Abbreviations used in this paper
 
: ALLN, 
 
N
 
-acetyl-leucyl-leucyl-nor-
leucinal; GST, glutathione-S-transferase; LDL, low density lipoprotein. 
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paraformaldehyde in buffer B lacking DTT for 15 min at 4
 
8
 
C, rinsed twice
in buffer C, and then held in buffer C at 4
 
8
 
C until assayed.
 
Indirect 
 
125
 
I-labeled Streptavidin-binding Assays. 
 
Coated pit budding was
monitored by measuring the amount of clathrin on the membrane as pre-
viously described (39). The same indirect method was used to measure the
amount of spectrin and annexin VI on membranes. The primary mAb an-
tibodies were X-22 (1 
 
m
 
g/ml), anti-annexin VI (1 
 
m
 
g/ml) and antispectrin
(4.2 
 
m
 
g/ml). Bound antibodies were detected using biotinylated horse
anti–mouse IgG (1 
 
m
 
g/ml), and 
 
125
 
I-labeled streptavidin (1 
 
m
 
Ci/ml).
 
LDL Uptake Assay. 
 
The
 
 
 
uptake of 
 
125
 
I-labeled LDL (22) and fluores-
cent LDL (2) were measured using standard methods. All measurements
were made on normal human fibroblasts induced to express LDL recep-
tors for 2 d. For fluorescence detection, the cells were fixed with 3% form-
aldehyde in buffer C, mounted in SlowFade™,
 
 
 
and then visualized with a
Zeiss photomicroscope III.
 
Microinjection. 
 
Normal human fibroblasts were induced to express
LDL receptors as described (22). The cells were placed in medium C and
then comicroinjected with FITC-dextran (3 mg/ml) and the indicated pro-
tein using an Eppendorf automated microinjection system (model 5171;
Eppendorf Scientific, Inc., Hamburg, Germany). The cells were allowed
to recover for 1 h at 37
 
8
 
C in medium B before the uptake of fluorescent-
LDL was measured as described above.
 
Electron Microscopy. 
 
Normal human fibroblasts induced to express
LDL receptors were incubated in the presence or absence of 500 
 
m
 
M of
ALLN for 1 h, fixed, and then prepared for thin-section EM. The number
of coated pits was quantified as previously described (61).
 
Other Methods. 
 
Protein concentrations were determined using the
Bradford assay (Bio-Rad Laboratories, Hercules, CA).
 
Results
 
Annexin VI Binds to Inner Membrane Surface
 
Coated pit budding from membranes attached to a solid
substratum at 4
 
8
 
C is detected using an indirect radioim-
mune assay that measures the relative amount of clathrin
on the membrane (43). Previously, we documented that
clathrin loss is an accurate gauge of coated vesicle forma-
tion (39). Although annexin VI appears to be essential for
budding in vitro, other cytosolic factors are also needed. In
an effort to identify these factors, we set up a standard re-
action mixture consisting of cytosol deficient in active an-
nexin VI (refer to Materials and Methods
 
 
 
for details), var-
ious recombinant forms of annexin VI, Ca
 
1
 
2
 
, and ATP
(Fig. 1 
 
A
 
). No loss of clathrin was detected when mem-
branes were incubated at 37
 
8
 
C in the presence of buffer
(Fig. 1 
 
A
 
, bar 
 
1
 
) and only a modest loss occurred in the
presence of inactive cytosol (Fig. 1 
 
A
 
, bar
 
 2
 
). By contrast,
when 1 nM recombinant annexin VI (AnxVI
 
wt
 
) was added
to the cytosol, membrane clathrin declined by 75% (Fig. 1
 
A
 
, bar
 
 3
 
). Annexin VI lacking the last four calcium binding
repeats (AnxVI
 
D
 
379
 
) supported budding to the same extent
(Fig. 1 
 
A
 
, bar
 
 4
 
). A recombinant annexin VI missing the
last six repeats (AnxVI
 
D
 
192
 
), however, lacked budding ac-
tivity (Fig. 1 
 
A
 
, bar 
 
5
 
).
In contrast to its inability to support budding, AnxVI
 
D
 
192
 
inhibited the activity of AnxVI
 
wt
 
 (Fig. 1 
 
B
 
). Normal clath-
rin loss occurred in the presence of AnxVI
 
wt
 
 alone but
with increasing concentrations of AnxVI
 
D
 
192
 
 in the mix-
ture, budding was progressively inhibited. At a molar ratio
of 12 AnxVI
 
D
 
192
 
:1 AnxVI
 
wt
 
, budding was inhibited 
 
z
 
75%
compared with inactive cytosol alone (
 
e
 
, 
 
dotted line
 
).
The site(s) of action for annexin VI may be in the cyto-
sol, at the plasma membrane, or both. To distinguish be-
tween these possibilities, we measured the ability of pre-
bound annexin VI to support budding (Fig. 2 
 
A
 
). Membranes
were incubated in the presence (Fig. 2 
 
A
 
, bars 
 
4
 
–
 
6
 
) or ab-
Figure 1. Effects of recombinant wild-type annexin VI (A) and
truncated annexin VI (A and B) on budding of clathrin-coated
pits. (A) Fibroblast membranes were attached at 48C and then
warmed to 378C for 10 min in the presence of either buffer alone
or cytosol containing 1 nM of the indicated recombinant protein.
At the end of the incubation, the amount of clathrin loss was
measured as described. Maximum clathrin value was 27,185 cpm/
well of 125I-labeled streptavidin bound with a background of 731
cpm/well.  (B)  Fibroblast membranes were warmed in cytosol
containing 1 nM wild-type annexin VI (Anx VIwt) plus the indi-
cated concentration of AnxVID192 (h) or BSA (s). Maximum
clathrin value was 32,475 cpm/well with a background of 1,961
cpm/well. All values are the average of triplicate measurements 6
the standard deviation.The Journal of Cell Biology, Volume 142, 1998 940
sence (bars 1–3) of buffer B containing annexin VI for 15
min at 48C. The membranes were washed and either not
warmed (Fig. 2 A, bar 4) or warmed to 378C in the pres-
ence of either inactive cytosol (Fig. 2 A, bars 2 and 6),
buffer alone (Fig. 2 A, bars 1 and 5) or inactive cytosol
containing AnxVIwt (Fig. 2 A, bar 3). Just as much clathrin
loss occurred from membranes preincubated in the pres-
ence of AnxVIwt as from untreated membranes that were
warmed in cytosol containing AnxVIwt (Fig. 2 A, compare
bar 3 with 6). Buffer alone did not support budding under
any condition (Fig. 2 A, bars 1 and 5), nor did cytosol in
the absence of AnxVIwt (Fig. 2 A, bar 2). These results
suggest prebound annexin VI can activate cytosolic factors
necessary for the budding reaction.
We used a radioimmune assay to directly measure mem-
brane binding of annexin VI (Fig. 2 B). Membranes at-
tached by standard methods were incubated for 15 min at
48C in the presence of buffer B containing cytosol, Ca12,
ATP, and various concentrations of AnxVIwt (s). As the
concentration was increased, there was a corresponding
increase in the amount of AnxVIwt associated with the
membrane. The level of bound AnxVIwt plateaued when
the concentration reached 1 nM, suggesting a high-affinity
interaction. If we substituted AnxVID192 (u) for AnxVIwt,
no binding was detected. AnxVID379 bound as well as wild-
type (data not shown). Finally, binding occurred in the
presence of buffer alone, so cytosolic factors are not re-
quired (Fig. 2 C, bar 3).
The binding characteristics of annexin VI suggested it
might be interacting with a protein on the inner surface,
rather than a phospholipid. Previously, b-spectrin was
identified as an annexin VI–binding protein and the bind-
ing site localized to a 28-kD fragment from the NH2-termi-
nal portion of the molecule (59). We expressed in bacteria
a cDNA coding for the first 272 amino acids of human b
spectrin (b-Spec1–272), which contains the putative annexin
VI–binding site, and purified the peptide. The presence of
a threefold excess of this peptide completely blocked the
binding of AnxVIwt to membranes (Fig. 2 C, compare bar 4
Figure 2. Annexin VI binding to attached membranes (B and C)
supports coated pit budding (A). (A) Attached membranes were
incubated for 15 min at 48C in the presence of either buffer alone
(bars 1–3) or buffer containing 1 nM AnxVIwt (bars 4–6). Mem-
branes were either assayed immediately (bar 4) or warmed to
378C for 10 min in the presence of either buffer (bars 1 and 5), cy-
tosol alone (bars 2 and 6), or cytosol containing AnxVIwt (bar 3).
Maximum clathrin value was 36,902 cpm/well with a background
of 1,182 cpm/well. (B) Attached membranes were incubated in
the presence of cytosol containing the indicated concentration of
either AnxVIwt (s) or AnxVID192 (h) for 15 min at 48C. The
membranes were washed and assayed for the amount of bound
annexin VI as described. Background binding of BSA ranged be-
tween 3,056 cpm/well and 8,654 cpm/well and was subtracted
from all values. (C) Attached membranes were either not treated
(bar 1) or incubated at 48C for 15 min in the presence of either
buffer alone (bar 2), buffer plus 1 nM AnxVIwt (bar 3), cytosol
plus 1 nM AnxVIwt (bar 4) or cytosol plus 1 nM AnxVIwt and in 3
nM b-spectrin1–272 (bar 5). Membranes were then assayed for the
amount of annexin VI bound. Background binding to BSA has
been subtracted from all values. All values are the average of
triplicate measurements 6 the standard deviation.Kamal et al. Spectrin Removal during Receptor-mediated Endocytosis 941
with 5). These results indicate that spectrin is a component
of a high-affinity membrane-binding site for annexin VI.
Annexin VI Mediates Remodeling of
Membrane Cytoskeleton
The binding of annexin VI to spectrin may be required for
remodeling of the membrane cytoskeleton before budding
of coated pits. A radioimmune assay was used to measure
the relative amount of spectrin on the membrane before
and after the completion of the budding reaction (Fig. 3
A). Freshly isolated membranes had z6 3 103 cpm/well of
antispectrin IgG-binding activity (Fig. 3 A, compare bar 1
with 2). Antispectrin IgG binding activity did not change
when the membranes were warmed to 378C in the pres-
ence of buffer (Fig. 3 A, bar 3) or buffer plus AnxVIwt (Fig.
3 A, bar 6), indicating no loss of spectrin under these con-
ditions. Binding activity declined by z50%, however,
when the buffer was replaced with the standard budding
mixture containing AnxVIwt (Fig. 3 A, bar 4). Substitution
of AnxVIwt with AnxVID192, which does not affect budding
(refer to Fig. 1 A), did not stimulate the loss of spectrin
(Fig. 3 A, bar 5). Therefore, conditions that support bud-
ding of coated pits reduce the level of spectrin that can be
detected on the membrane with this radioimmune assay.
If the binding of annexin VI to spectrin is linked to spec-
trin removal during budding, then blocking this interaction
should inhibit budding. We tested the effects of different
concentrations of b-Spec1–272 (Fig. 3 B), which inhibits an-
nexin VI binding (refer to Fig. 2 C). We saw a 15% clath-
rin loss when membranes were warmed to 378C in buffer
alone (s, on the ordinate) and z27% loss when cytosol
lacking AnxVIwt activity was used (e, horizontal dotted
line). The inclusion of AnxVIwt in the cytosol caused a
65% loss of clathrin, but the loss was progressively sup-
pressed by the addition of increasing amounts of b-Spec1–
272 to the mixture (h). At the highest concentration of
b-Spec1–272, we observed an z90% inhibition of AnxVIwt –
induced budding activity relative to cytosol alone.
Another potential way to interfere with spectrin re-
moval is to use a specific cross-linking agent such as a
polyclonal antispectrin antibody (Fig. 3 C). Inactive cyto-
sol caused an z20% loss of clathrin (e, on the ordinate)
but the addition of AnxVIwt stimulated a 62% loss. With
increasing concentrations of antispectrin serum added to
the mixture, however, there was a progressive decline in
the presence of spectrin as described. Background was 500 cpm/
well. (B) Attached membranes were incubated for 10 min at 378C
in the presence of cytosol alone (e, dashed line) or cytosol con-
taining 1 nM AnxVIwt plus the indicated concentration of b-spec-
trin peptide (h). At the end of the incubation, the amount of
clathrin loss was measured as described. Maximum clathrin value
was 30,216 cpm/well with a background of 1,859 cpm/well. (C)
Attached membranes were incubated for 10 min at 378C in the
presence of cytosol (e, on the ordinate) or cytosol containing 1
nM AnxVIwt plus the indicated concentration of rabbit antihu-
man spectrin serum (h). At the end of the incubation, the amount
of clathrin loss was measured as described. Maximum clathrin
value was 28,125 cpm/well with a background of 1,407 cpm/well.
All values are the average of triplicate measurements 6 the stan-
dard deviation.
Figure 3. Spectrin loss from membranes (A) accompanies bud-
ding (B and C) of coated pits. (A) Attached membranes were
warmed to 378C for 10 min in the presence of buffer alone (bar
3), buffer plus AnxVIwt (bar 6), cytosol plus AnxVIwt (bar 4), or
cytosol plus AnxVID192 (bar 5). All wells were then assayed forThe Journal of Cell Biology, Volume 142, 1998 942
the loss of clathrin from the membrane. At the highest
concentration (400 mg/ml), clathrin loss was reduced be-
low the amount that occurred in the presence of buffer
alone (Fig. 3 C, compare with s on the ordinate). Since an-
nexin VI binding was not affected by the presence of the
spectrin antiserum (data not shown), the antibody appears
to block budding by physically preventing spectrin remod-
eling.
Spectrin-bound annexin VI could regulate the remodel-
ing of membrane spectrin by activating a cytosolic pro-
tease. Since calpain I has been implicated in removing
spectrin from the membrane (31, 34), we used the cysteine
protease inhibitor ALLN to see if it would block annexin
VI–dependent removal of spectrin (Fig. 4 A). Compared
with untreated membranes (Fig. 4 A, bar 1), annexin VI
caused a significant decrease in the amount of spectrin on
the membrane (Fig. 4 A, bar 2). This loss of spectrin was
markedly inhibited by adding 5 (Fig. 4 A, bar 3) and 10
mM of ALLN (Fig. 4 A, bar 4) to the incubation. The
DMSO carrier used to solubilize the ALLN had no effect
(Fig. 4 A, bar 5).
ALLN also inhibited coated pit budding (Fig. 4 B). In-
cubation of membranes in the presence of cytosol plus
AnxVIwt caused an z60% loss of clathrin. The presence of
5 mM ALLN inhibited loss by 50% (Bar 3), but raising the
concentration to 10 mM (Fig. 4 B, bar 4) completely inhib-
ited budding. The endogenous calpain inhibitor, calpasta-
tin, (7 mM) caused a 50% inhibition whereas serine pro-
tease inhibitors such as pepstatin and PMSF had no effect
(data not shown). These in vitro results suggest the func-
tion of annexin VI during endocytosis is to link the activity
of a calpain I–like protease to the remodeling of the spec-
trin cytoskeleton.
Figure 4. ALLN inhibits loss of spectrin (A) and coated pit bud-
ding (B) in vitro. (A) Attached membranes were either not
treated (bar 1) or incubated at 378C for 10 min in the presence of
cytosol (bars 2–5) containing the indicated additions. At the end
of the incubation, the membranes were assayed for the amount of
spectrin as described. (B) Attached membranes were incubated
at 378C in the presence of either buffer (bar 1) or cytosol (bars 2–5)
containing the indicated additions. At the end of the incubation,
the percent loss of clathrin was measured as described. Maximum
clathrin value was 29,098 cpm/well with a background of 1,114
cpm/well. All values are the average of triplicate measurements 6
the standard deviation.
Figure 5. ALLN transiently inhibits uptake of 125I-labeled LDL.
Expression of LDL receptors was induced in normal human fi-
broblasts by standard methods. The cells were preincubated in
the presence (s) or absence (h) of 500 mM ALLN for 1 h before
the addition of 15 mg/ml of 125I-labeled LDL 6 50-fold excess of
cold LDL. The cells were then incubated further for the indicated
time before the amount of internalized [125I]LDL was measured
as described. Each value is the average of duplicate measure-
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Annexin VI Required for Normal Budding In Vivo
If annexin VI is involved in receptor-mediated endocyto-
sis, the results of the in vitro analysis suggest ALLN
should inhibit LDL internalization (Fig. 5). Human fibro-
blasts were incubated for different times in the presence of
media containing 125I-labeled LDL, plus or minus the addi-
tion of 500 mM of ALLN. Control cells internalized LDL
at a constant rate (h) for the first 30–60 min of the incuba-
tion, after which the rate began to plateau. The presence
of ALLN in the media totally blocked LDL uptake for the
first 30 min of incubation (s). Surprisingly, the cells then
began to take up LDL, which continued for the duration
of the incubation. These results suggested ALLN initially
blocks coated pit budding in vivo, but the cells overcome
the inhibition by activating an alternative pathway.
Several studies have shown that when the coated pit
pathway is inhibited, cells activate an alternative internal-
ization pathway (38). Cells that have recovered from
ALLN were able to internalize LDL, a process thought to
require receptor clustering by clathrin coats (5). To better
understand the mechanism of recovery from ALLN, we
used electron microscopy to examine cells that had been
incubated in the presence or absence of ALLN for 60 min
(Table I). Both sets of cells had normal-appearing clath-
rin-coated pits (data not shown), but the ALLN-treated
cells contained nearly twice as many pits (0.18 verses 0.32/
mM). The increase in the number of coated pits was con-
firmed by immunofluorescence (data not shown). In addi-
tion, the anti-clathrin IgG radioimmune assay showed that
attached plasma membranes from ALLN pretreated cells
contained over twofold more clathrin than membranes
from control cells (2.3 3 104 cpm of 125I-labeled streptavi-
din binding (control) compared with 5.8 3 104 [ALLN]).
Therefore, ALLN causes an increase in the number of
coated pits at the cell surface.
Coated pits that assembled in the presence of ALLN did
not require annexin VI for budding in vitro (Fig. 6 A). We
incubated cells in the presence of ALLN for 1 h and pre-
pared membranes. There was little loss of clathrin when
these membranes were warmed to 378C in the presence of
buffer (Fig. 6 A, bar 1). Replacing the buffer with inactive
cytosol, however, resulted in a 60% loss of clathrin (Fig. 6
A, bar 2). The same amount of clathrin loss occurred re-
gardless of whether annexin VI was added to the cytosol
(Fig. 6 A, compare bar 3 with 2) or if ALLN was present in
the complete budding mixture (Fig. 6 A, compare bar 4
with 3). Consistent with these results, membranes from
ALLN-treated cells did not lose any spectrin during bud-
ding (Fig. 6 B, compare bars 3 and 4 with 2). Apparently
cells overcome the effects of ALLN by assembling a new
population of pits that are not functionally or structurally
linked to the spectrin cytoskeleton.
Table I. Effect of ALLN on Number of Coated Pits
Treatment
Number of cells
evaluated
mM of
membrane
Total
coated pits
Coated
pits/mM
Control 106 130 24 0.18
ALLN 114 138 44 0.32
Human fibroblasts were incubated in the presence or absence of 500 mM of ALLN for
1 h at 378C, fixed, and then prepared for EM thin-section analysis as described.
Figure 6. Budding (A) is no longer linked to spectrin loss (B) in
membranes from ALLN-treated cells. (A) Attached membranes
obtained from cells incubated in the presence of ALLN for 1 h
were warmed to 378C in the presence of buffer alone (bar 1) or
warmed in the presence of cytosol (bars 2–4) containing the indi-
cated additions. At the end of the incubation, the percent loss of
clathrin was measured as described. Maximum clathrin value was
58,321 cpm/well with a background of 2,536. (B) Attached mem-
branes obtained from cells incubated in the presence of ALLN
for 1 h were either not treated (bar 2) or warmed to 378C for 10
min in the presence of cytosol (bars 3 and 4) containing the indi-
cated additions. At the end of the incubation, the membranes
were assayed for the amount of spectrin as described. Back-
ground binding is shown in bar 1. In both experiments, each value
is the average of triplicate measurements 6 the standard devia-
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We next looked at the fate of the LDL internalized by
ALLN-treated cells (Fig 7, A and B). Cells were preincu-
bated in the presence (Fig. 7 B) or absence (Fig. 7 A) of
ALLN for 60 min before adding 25 mg/ml of fluorescent
LDL to each dish and continuing the incubation an addi-
tional 90 min. Untreated cells had numerous large fluores-
cent vesicles aggregated near the center of the cell (Fig. 7
A). By contrast, the fluorescent vesicles in ALLN-treated
cells were smaller, more uniform in size and scattered
throughout the cell. We also found that LDL degradation
was markedly inhibited in ALLN-treated cells (Table II).
Using a standard 5-h uptake assay, z50% of the internal-
ized  125I-labeled LDL was degraded in control cells,
whereas very little degradation was detected in ALLN-
treated cells. Instead, these cells contained twofold more
nondegraded 125I-labeled LDL than control cells.
The dominant-negative–acting AnxVID192 had the same
effect on coated pit budding and spectrin loss in vitro as
ALLN (refer to Fig. 1 B and Fig. 3 A). Therefore, we mi-
croinjected AnxVIwt and AnxVID192 into normal human fi-
broblasts and compared the effect of these proteins on the
uptake of fluorescent LDL (Fig. 8, A–D and Table III).
Cells were injected with the indicated recombinant protein
mixed with FITC-labeled dextran to mark the cell, allowed
to recover for 1 h, and then incubated an additional 1 h in
the presence of fluorescent LDL. Cells injected with the
AnxVIwt (Fig. 8 A) took up normal amounts of pyrene-
labeled LDL, compared with nearby uninjected cells, and
delivered it to the perinuclear area of the cell (Fig. 8 B).
Internalization of LDL in cells injected with AnxVID192
(Fig. 8 C), by contrast, was markedly reduced (Fig. 8 D)
compared with neighboring uninjected cells. In addition,
the LDL-positive vesicles in these cells tended to be more
randomly distributed. Quantification of these results (Ta-
ble III) showed that 83% of the cells injected with
AnxVID192 had a reduced uptake of LDL and 17% did not
internalize any detectable LDL.
Like AnxVID192, microinjection of antispectrin IgG also
inhibited the uptake of fluorescent LDL (Fig. 8 E–H and
Table III). Control IgG did not affect the uptake of the
LDL (Fig. 8, E and F), whereas antispectrin IgG markedly
reduced uptake (Fig. 8, G and H). Table III shows that the
number of affected cells injected with antispectrin IgG was
similar to what was seen with AnxVID192. Therefore, three
different agents that prevent budding of coated pits in
vitro (ALLN, AnxVID192, and antispectrin IgG) also block
internalization of LDL in vivo.
Discussion
We have discovered a new set of protein–protein interac-
tions that operate during normal receptor-mediated en-
docytosis in human fibroblasts. A combination of in vitro
and in vivo experiments support the conclusion that an-
nexin VI couples the proteolytic activity of a calpain-like
protease to the remodeling of plasma membrane spectrin
during budding in human fibroblasts. Three different re-
agents (ALLN, AnxVID192, and antispectrin IgG) that in-
terfere with the removal of spectrin from plasma mem-
branes block coated pit budding both in vitro and in vivo.
Cells adapt to blocking conditions by assembling a new set
of pits that are able to bud both in vitro and in vivo with-
out annexin VI–dependent spectrin remodeling. The en-
dosomes that form under these conditions, however, tend
to be randomly distributed in the cell rather than migrate
to the centrosome region. Therefore, annexin VI is not part
of the machinery that physically mediates invagination and
scission, but rather is necessary for the formation of endo-
somes that can move to the correct location in the cell.
These results extend the list of molecular interactions
known to be required for coated pit budding in fibroblasts.
Clathrin lattice assembly is the end product of interactions
between AP2 and its high-affinity membrane binding site
(41, 62), AP2 and clathrin (35), and clathrin with itself
(35). Invagination of the membrane is driven by the regu-
lated (36) rearrangement of the lattice without the partici-
pation of additional cytoplasmic factors (39). At the end of
the invagination stage, the pit is a nascent vesicle held onto
the membrane by a slender membrane stalk. The scission
of this stalk, which may be physically mediated by dy-
namin (8, 17, 32), apparently cannot release the vesicle un-
less spectrin remodeling takes place. Remodeling, in turn,
requires the binding of annexin VI to spectrin and the ac-
tivity of a calpain-like, cytoplasmic protease. Only 50% of
the spectrin is lost during normal budding (refer to Fig. 3)
and some of this probably leaves the membrane with the
new coated vesicle. Therefore, annexin VI targets the ac-
tion of the calpain protease to regions of cytoskeleton that
must be freed so scission can release the vesicle.
A connection between the spectrin cytoskeleton and
budding of coated pits has not been detected before. Spec-
trin, actin, band 4.1, and ankyrin form an oligomeric com-
plex (11) that can assemble into a two-dimensional lattice
on the cytoplasmic surface of both internal (9) and surface
membranes (11). Ankyrin and band 4.1 are both able to
Figure 7. Endosomes are
mislocalized (A and B) in
cells incubated in the pres-
ence of ALLN. Human fibro-
blasts were incubated in the
presence (B) or absence (A)
of 500 mM ALLN for 1 h at
378C before the addition of
25  mg/ml of fluorescent LDL.
The cells were incubated an
additional 90 min before di-
rect visualization.
Table II. Effect of ALLN on Degradation of LDL
Treatment Receptor-bound protein Internalized protein Degraded protein
ng/mg ng/mg ng/mg
Control 50 910 1200
ALLN 160 2900 80
Cells were incubated in the presence of 500 mM of ALLN for 1 h before the addition
of 15 mg/ml of [125I]LDL 6 50-fold excess cold LDL. Cells were incubated an addi-
tional 5 h before the amount of surface, internalized, and then degraded [125I]LDL
was measured as described. All values are the average of duplicate measurements.Kamal et al. Spectrin Removal during Receptor-mediated Endocytosis 945
bind multiple membrane proteins and tether them to spec-
trin–actin strands (15). Bound proteins have a restricted
lateral mobility in the plane of the membrane (45), which
presumably causes them to collect in spectrin-rich regions.
Thus, the spectrin lattice shares with the clathrin lattice
the ability to create membrane domains capable of carry-
ing out specific functions for the cell. The function of the
clathrin lattice is to prepare a portion of membrane for
transport to other locations whereas the spectrin lattice
seems adapted for retaining the properties of the originat-
ing membrane. The function of annexin VI in these cells,
therefore, is to mobilize the elements needed to discon-
nect clathrin domains from spectrin during budding. In
this capacity, annexin VI provides a vital communication
link between retained and departing portions of a specific
region of plasma membrane.
The importance of this link was revealed in cells that
were exposed to ALLN for greater than 30 min. After the
resumption of receptor-mediated endocytosis there were
nearly twofold more coated pits and twice as much clath-
rin on the membrane. This suggests that in the absence of
spectrin remodeling, coated pits that are linked to spectrin
become trapped at the surface. The cell compensates by
assembling a new population of pits that are not associated
with spectrin and, therefore, do not require annexin VI for
Figure 8. Microinjection of AnxVID192 or anti-
spectrin IgG inhibits LDL uptake. Human fibro-
blasts were microinjected with 3 mg/ml FITC-
dextran and 100 mM AnxVIwt (A and B) or 100
mM AnxVID192 (C and D) or 300 mg/ml anti-rab-
bit IgG (E and F) or 300 mg/ml antispectrin IgG
(G and H). The cells were allowed to recover for
1 h at 378C and then the uptake of fluorescent
LDL (25 mg/ml) for 1 h at 378C was measured. B,
D, F, and H show LDL uptake and A, C, E, and
G show FITC-dextran staining of the same cells.
Table III. Effect of AnxVID192 and Antispectrin on LDL Uptake
Number of
cells evaluated
Percentage of cells
Protein microinjected 11 Uptake 1 Uptake No uptake
AnxVIwt 48 94 6 0
AnxVID192 42 0 83 17
Control IgG 45 91 9 0
Antispectrin IgG 39 0 77 23
Human fibroblasts were microinjected with the indicated protein mixed with FITC-
labeled dextran to mark the injected cell and then incubated for 1 h. The cells were in-
cubated for an additional 1 h in the presence of fluorescent LDL as described. Each
value is the average of duplicated experiments.The Journal of Cell Biology, Volume 142, 1998 946
budding. The endosomes generated by these new pits did
not migrate to the center of the cell.
The intracellular movement of membrane vesicles re-
quires both microfilament (44) and microtubule (23, 25)
components of the cytoskeleton. Motor proteins such as
myosin, kinesin, and dynein bound to vesicle membranes are
able to propel the vesicle along the appropriate cytoskele-
tal track (25). Microtubules and the centrosome-directed
motor, dynein, appear to be necessary for the fusion of early
with late endosomes during endocytosis (6, 12, 27). Dynein
binds to dynactin, a 20 S macromolecular complex involved
in maintaining the centrosomal organization of membranes
like the Golgi apparatus (1, 57). Another protein in the dy-
nactin complex is centractin (14). Centractin is an actin-
related protein that appears to associate with spectrin (33).
The two colocalize in cells overexpressing centractin, and
spectrin coprecipitates with the dynactin complex. Dynac-
tin has been proposed to be the physical linkage between
dynein bound to microtubules and spectrin bound to vesi-
cle membranes (33). If so, then early endosomes lacking
spectrin would not link with the dynein–microtubule sys-
tem and, therefore, be unable to migrate. This may be what
happens when annexin VI activity is blocked in fibroblasts.
The endosomes that form lack the spectrin necessary to
track on microtubules and, as a consequence, fusion with late
endosomes containing hydrolytic enzymes (18) is impaired.
Contrary to our initial thinking (40), annexin VI is not
an essential component of the coated pit budding machin-
ery. As far as we can tell, it is only needed to release clath-
rin-coated pits from spectrin. Not all portions of the
plasma membrane are covered with a spectrin cytoskele-
ton. The apical surface of polarized epithelial cells, for ex-
ample, is relatively deficient in spectrin (45). Annexin VI
may not be needed to release coated vesicles from this
membrane. Other cytoskeletal factors appear to come into
play at this surface because drugs that depolymerize actin
microfilaments inhibit coated pit budding from apical
membranes, but not from spectrin-rich basolateral mem-
branes (26). Therefore, not all coated pits at the cell sur-
face are equivalent. Superimposed on the basic budding
machinery are molecular interactions that must take place
to facilitate the release of the budding pit from the particu-
lar membrane of origin.
These results suggest that coated pit budding may be
normal in cells lacking annexin VI. Consistent with this
conclusion, human A431 squamous carcinoma cells lack-
ing annexin VI are able to internalize and recycle transfer-
rin receptors (52). Receptor-mediated endocytosis in these
cells is inhibited after disruption of actin filaments (37),
suggesting that budding is primarily occurring from mem-
brane domains that are apical-like in character, so annexin
VI should not be needed. Interestingly, the ligand-induced
degradation of EGF and its receptor is markedly slower in
these cells (54) compared with human fibroblasts (55), ow-
ing to the diversion of the receptor–EGF complex into a
recycling pathway (53). The proportion of internalized
LDL that gets degraded in 5 h is also significantly less in
these cells compared with matched sets of CHO cells (re-
fer to Table II) (4).
In conclusion, endosomes appear to acquire a set of in-
formation during budding that determines where they will
migrate in the cell. This information also specifies the
membrane of origin for the vesicle. The control of this as-
pect of membrane traffic is distinctly different in character
and molecular mechanism than the control of membrane–
membrane recognition and fusion (48, 50). The major
function of the annexin family of proteins in membrane
traffic (16), therefore, may be to regulate the placement
and removal of tags that imprint vesicles with the informa-
tion necessary for them to assume the correct spatial dis-
tribution in the cell.
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